Omic Profile in Autism Spectrum Disorder: From Cellular Level Towards Future Treatments
Recruiting
N/A
Interventional Study
Autism Spectrum Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 3 – 15
- Sex
- Any
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 100 (estimated)
- Sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is an interventional non pharmacological study in pediatric patientis affected by Autism Spectrum Disorder. It ams to create a collection of iPSCs and hiNSCs derived from deeply characterized ASD patients, to omics-characterize the cells, and to study the behavioral pattern of microglia-like cells in the onset of ASD.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Defined ASD diagnosis according to DSM-5 criteria
* Age 3-15 years
* Informed consent signed by the guardians/legal representatives.
Exclusion Criteria:
* Exclusion criteria for Group 1 will be: having a defined genetic diagnosis or an overall clinical presentation strongly …
Contacts